NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Fujian Genohope Biotech Ltd.

Fujian Genohope Biotech Ltd.

Private
PutianHealthcare & Life Scienceshttps://www.genohopebio.com/

Last Round

Series C

Oct 11, 2024

Company Overview

Fujian Genohope Biotech Ltd. is a pharmaceutical company that specializes in the research, development, and manufacturing of high-potency polypeptide APIs and injectable drug preparations.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Pharma Supply Chain, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Hardware Sales

AI Layer

Non-AI

Keywords

contract development and manufacturing organizationCDMOpeptide APIsterile injectablesGLP-1 manufacturingactive pharmaceutical ingredientsAPIGMP manufacturingpeptide synthesispharmaceutical outsourcingclinical trial supportanalytical testingfinished dosage formsdrug development servicesbiotech supply chain

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Fujian Genohope Biotech Ltd. Comparables

Compare Fujian Genohope Biotech Ltd. with similar companies based on industry and business-model similarity.

Fujian Genohope Biotech Ltd. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Medtide Inc.
82%
Sinopep-Allsino Biopharmaceutical
80%
Zhejiang Peptides Biotech Co., Ltd.
79%

Fujian Genohope Biotech Ltd. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series COct 11, 2024
Series B ExtensionJul 25, 2023
Series AMar 1, 2023
Series BApr 7, 2022
Early FundingApr 1, 2021
Joint Venture
Jan 14, 2019

Key People

Founding team and executive leadership

Helton Chang

CEO

Executive Team

Fujian Genohope Biotech Ltd. Investors

Notable investors and investment history

Fujian Genohope Biotech Ltd. investors
InvestorRounds
Hosencare BrothersSeries B Extension, Joint Venture, Series C, Early Funding
Hosen CapitalSeries B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Nov 28, 2024

    Grew 600% QoQ from 1 to 7 employees.

  • Mar 1, 2023

    Completed a Series A funding round.

Fujian Genohope Biotech Ltd. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Fujian Genohope Biotech Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Fujian Genohope Biotech Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersPutian
Employee Range9
Year Founded2019
Last FundingOct 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.